COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,946 Articles (22,604 medRxiv, 8,342 bioRxiv)

Most recent first Previous |  Page 1538: Articles 15371-15380  | Next

SARS-CoV-2 bearing a mutation at the S1/S2 cleavage site exhibits attenuated virulence and confers protective immunity
Sasaki, M., Toba, S., Itakura, Y., Herman M. Chambaro, H. M., Mai, K., Tabata, K., Intaruck, K., Uemura, K., Sanaki, T., Sato, A., Hall, W. W., Orba, Y., Sawa, H.
10.1101/2021.04.29.442060 — Posted: 2021-04-30
N440K variant of SARS-CoV-2 has Higher Infectious Fitness
Tandel, D., Gupta, D., Sah, V., Harshan, K. H.
10.1101/2021.04.30.441434 — Posted: 2021-04-30
LY-CoV1404 potently neutralizes SARS-CoV-2 variants
Westendorf, K., Zentelis, S., Foster, D., Vaillancourt, P., Wiggin, M., Lovett, E., Hendle, J., Pustilnik, A., Sauder, J. M., Kraft, L., Hwang, Y., Siegel, R. W., Chen, J., Heinz, B. A., Higgs, R. E., Kalleward, N., Jepson, K., Goya, R., Smith, M. A., Collins, D. W., Pellacani, D., Xiang, P., de Puyraimond, V., Ricicova, M., Devorkin, L., Pritchard, C., O'Neill, A., Cohen, C., Dye, J., Huie, K. I., Badger, C. V., Kobasa, D., Audet, J., Freitas, J. J., Hassanali, S., Hughes, I., Munoz, L., Palma, H. C., Ramamurthy, B., Cross, R. W., Geisbert, T. W., Lanz, I., Anderson, L., Sipahimalani, P., Corbett, K. S., Wang, L., Yang, E. S., Zhang, Y., Shi, W., Graham, B. S., Mascola, J. R., Fernandez, T. L., Hansen, C. L., Falconer, E., Jones, B. E., Barnhart, B. C.
10.1101/2021.04.30.442182 — Posted: 2021-04-30 Discussion: Onsite
Cell-free glycoengineering of the recombinant SARS-CoV-2 spike glycoprotein
Ruhnau, J., Grote, V., Juarez-Osorio, M., Bruder, D., Rapp, E., Rexer, T. F. T., Reichl, U.
10.1101/2021.04.30.442139 — Posted: 2021-04-30
ACE2 glycans preferentially interact with the RBD of SARS-CoV-2 over SARS-CoV
Acharya, A., Lynch, D., Pavlova, A., Pang, Y. T., Gumbart, J.
10.1101/2021.04.29.442038 — Posted: 2021-04-30
Allosteric Cross-Talk Among SARS-CoV-2 Spike's Receptor-Binding Domain Mutations Triggers an Effective Hijacking of Human Cell Receptor
Spinello, A., Saltalamacchia, A., Borisek, J., Magistrato, A.
10.1101/2021.04.30.441093 — Posted: 2021-04-30
COVID-19 Vaccine Acceptance Among Healthcare Workers in a United States Medical Center
Moniz, M. H., Townsel, C., Wagner, A. L., Zikmund-Fisher, B. J., Hawley, S., Jiang, C., Stout, M. J.
10.1101/2021.04.29.21256186 — Posted: 2021-04-30
Wastewater-based estimation of the effective reproductive number of SARS-CoV-2
Huisman, J. S., Scire, J., Caduff, L., Fernandez-Cassi, X., Ganesanandamoorthy, P., Kull, A., Scheidegger, A., Stachler, E., Boehm, A. B., Hughes, B., Knudson, A., Topol, A., Wigginton, K. R., Wolfe, M. K., Kohn, T., Ort, C., Stadler, T., Julian, T. R.
10.1101/2021.04.29.21255961 — Posted: 2021-04-30
Original antigenic sin responses to heterologous Betacoronavirus spike proteins are observed in mice following intramuscular administration, but are not apparent in children following SARS-CoV-2 infection
Lapp, S. A., Edara, V. V., Lu, A., Lai, L., Hussaini, L., Chahroudi, A., Anderson, L. J., Suthar, M. S., Anderson, E. J., Rostad, C. A.
10.1101/2021.04.29.21256344 — Posted: 2021-04-30
Comparing Expression of OAS-RNaseL Pathway-Related Genes in SARS-CoV-2 and Similar Viruses
Chakravarty, N., Edillor, P. A., Huang, A. P., Torres, G. A., Usmani, M. T., Kadandale, P.
10.1101/2021.04.29.442063 — Posted: 2021-04-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).